Hecla Mining (NYSE:HL) Bolsa

HECLA MINING CO

Hecla Mining

Hecla Mining Co produces and explores silver, gold, zinc, and other metals. The operating business segments are Greens Creek, Lucky Friday, Keno Hill, and Casa Berardi. It generates maximum revenue from the Greens Creek segment. Geographically, It operates in Canada, the United States, and Mexico, and it derives a majority of its revenue from the United States.

Hecla Mining Co

Hapag-Lloyd AG

Wahed FTSE USA Shariah ETF

Heartland BancCorp Com.

H LUNDBECK A/S U/ADR A by H. Lundbeck A/S

H. Lundbeck AS

H LUNDBECK A/S U/ADR B by H. Lundbeck A/S

HERON LAKE BIOENERGY UNIT by Heron Lake Bioenergy LLC

Heron Lake BioEnergy LLC

HEIDELBERG MATERIALS AG by HEIDELBERG MATERIALS AG

Heidelberg Materials AG

Holoco Inc

THE HEALING COMPANY INC by The Healing Company Inc.

The Healing Co Inc

HEALTHCARE & MED INVT CP by HEALTHCARE & MED INVT CORP.

Healthcare & Medical Investment Corp

HENDERSON LD DEV S/ADR by Henderson Land Development Co., Ltd.

Henderson Land Development Co Ltd

HENDERSON LD DEV CO LTD by Henderson Land Development Co., Ltd.

Helios Energy Ltd

Helio Corp

Herbalife Ltd

HONG LEONG BANK BHD by Hong Leong Bank BHD

HONG LEONG FINCL GRP ORD by Hong Leong Financial Group BHD

Hong Leong Financial Group Bhd

HALFORDS GROUP PLC ORD by Halfords Group Plc

Halfords Group PLC

HALFORDS GROUP UNSP/ADR by Halfords Group Plc

HelloFresh SE

HILTON FOOD GROUP ADR by HILTON FOOD GROUP PLC

Hilton Food Group PLC

HOME LOAN FINCL CORP by Home Loan Financial Corp.

Home Loan Financial Corp

Lattice Strategies Trust Hartford Longevity Economy ETF

Heliogen Inc

HILLGROVE RES LTD by Hillgrove Resources Ltd.

Hillgrove Resources Ltd

Holmen AB

Houlihan Lokey, Inc. Class A Common Stock

Houlihan Lokey Inc

Helical PLC

Helia Group Ltd

Helios Technologies Inc

Harmonic Inc

HELLA KGAA HUECK ORD by Hella Gmbh & Co Kgaa

HELLA GmbH & Co KGaA

Pontus Protein Ltd

HELLA GMBH KGAA UNSP/ADR by Hella Gmbh & Co Kgaa

HALLMARK VENTURE GRP INC by Hallmark Venture Group, Inc.

Hallmark Venture Group Inc

HELLO PAL INTL INC ORD by Hello Pal Intl Inc

Hello Pal International Inc

HELLIX VENTURES INC by Hellix Ventures, Inc.

Hellix Ventures Inc

Holley Inc

Halma PLC

Hillman Solutions Corp

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Haleon PLC

Hamilton Lane Incorporated - Class A Common Stock

Hamilton Lane Inc

HIGH LINER FOODS INC by High Liner Foods Inc.

High Liner Foods Inc

Helo Corp

HELIUM ONE GLOBAL LTD by HELIUM ONE GLOBAL LTD.

Helium One Global Ltd

PREVISTO INTL HLDGS INC by Previsto International Holdings, Inc.

Previsto International Holdings Inc

HILONG HOLDING LTD ORD by Hilong Holding Limited

Hilong Holding Ltd

Healios KK

Hongli Group Inc

HELLENIC PETROLEUM SA ORD by HELLENiQ ENERGY Holdings SA

HELLENiQ ENERGY Holdings SA

HANG LUNG PPTYS LTD by Hang Lung Properties Ltd.

Hang Lung Properties Ltd

HANG LUNG PPTYS S/ADR by Hang Lung Properties Ltd.

HELLENIQ ENERGY HLDGS GDS by HELLENiQ ENERGY Holdings SA

HELLENIQ ENGY HLDGS GDR by HELLENiQ ENERGY Holdings SA

Hilliard Corp

Hillcrest Energy Technologies Ltd

HILLCREST ENERGY TECH LTD by HILLCREST ENERGY TECHNOLOGIES LTD.

HIGHLANDER SILVER CORP by HIGHLANDER SILVER CORP

Highlander Silver Corp

HALLENSTEIN G/H ORD by Hallenstein Glasson Hldgs, Ltd.

Hallenstein Glassons Holdings Ltd

Hilton Worldwide Holdings Inc. Common Stock

Hilton Worldwide Holdings Inc

NATIONAL HEALTHCRE PPTY by National Healthcare Properties, Inc.

National Healthcare Properties Inc

Hilan Ltd

HILTON FOOD GROUP PLC by HILTON FOOD GROUP PLC

NOBILIS HEALTH CORP COM

Cue Health Inc

HELLENIC TELECOMMUNS ORG by Hellenic Telecommunications Organization S.A.

Hellenic Telecommunication Organization SA

HELLENIC TELECOMMUNS ADR by Hellenic Telecommunications Organization S.A.

HLS THERAPEUTICS INC by HLS Therapeutics Inc.

HLS Therapeutics Inc

HEALTHTECH SOLUTIONS INC by Healthtech Solutions Inc.

Healthtech Solutions Inc

HOMELAND URANIUM CORP by HOMELAND URANIUM CORP

HEALTHEUNIVERSE INC by HEALTHeUNIVERSE, Inc.

Healtheuniverse Inc

HELVETIA HLDG AG UNSP/ADR by Helvetia Holding AG

Helvetia Holding AG

HilleVax Inc

Almost Never Films Inc Com

Helix Energy Solutions Group, Inc. Common Stock

Helix Energy Solutions Group Inc

Helix Acquisition Corp. II - Class A Ordinary Shares

Helix Acquisition Corp II

Hi-Lex Corp

Helix Wind Corp

HealthLynked Corp

A new SEC filing reveals that Catherine J Boggs, Director at Hecla Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>), made a notable insider purchase on June 10,.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000719413/000169347225000003//Archives/edgar/data/719413/000169347225000003/0001693472-25-000003-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday showed that Boggs purchased 17,681 shares of Hecla Mining. The total transaction amounted to $93,749. 
During Wednesday's morning session, Hecla Mining shares up by 0.08%, currently priced at $6.13.
<h3>Unveiling the Story Behind Hecla Mining</h3>
Hecla Mining Co produces and explores silver, gold, zinc, and other metals. The operating business segments are Greens Creek, Lucky Friday, Keno Hill, and Casa Berardi. It generates maximum revenue from the Greens Creek segment. Geographically, It operates in Canada, the United States, and Mexico, and it derives a majority of its revenue from the United States.
<h3>Hecla Mining's Financial Performance</h3>
Revenue Growth: Hecla Mining's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 37.89%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: With a high gross margin of 28.32%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, Hecla Mining exhibits below-average bottom-line performance with a current EPS of 0.05.
</li>
</ul>
Debt Management: Hecla Mining's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.27.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: Hecla Mining's P/E ratio of 51.08 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 3.84 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Hecla Mining's EV/EBITDA ratio of 12.92 exceeds industry averages, indicating a premium valuation in the market
</li>
</ul>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Insider transactions are not the sole determinant of investment choices, but they are a factor worth considering.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
<h3>Transaction Codes To Focus On</h3>
Navigating through the landscape of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, precisely detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000719413">Check Out The Full List Of Hecla Mining's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Insider Trades

Trading Ideas

Catherine J Boggs Of Hecla Mining Shows Optimism, Buys $93K In Stock

U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Monday.
Shares of Vera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) rose sharply during Monday's session after the company <a href="https://www.benzinga.com/news/health-care/25/06/45720783/kidney-health-focused-vera-therapeutics-stock-price-spikes-on-heels-of-successful-trial-data">released ORIGIN Phase 3 trial data.</a>
Participants treated with atacicept for immunoglobulin A nephropathy (IgAN) achieved a 46% reduction from baseline in proteinuria as measured by 24-hour urine protein-to-creatinine ratio (UPCR), with a statistically significant and clinically meaningful 42% reduction in UPCR compared to placebo (p&lt;0.0001) at week 36.
Vera Therapeutics shares jumped 56.6% to $29.67 on Monday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Applied Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) surged 44.8% to $9.89 after the company announced a 250MW AI data center lease with CoreWeave.</li>
<li>Kymera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) climbed 33.3% to $39.53 after the company announced clinical data for its Phase 1 Healthy volunteer study of KT-621.</li>
<li>Blueprint Medicines Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) gained 26.2% to $127.93 after the company announced that Sanofi will acquire them for $9.5 billion.</li>
<li>Cleveland-Cliffs Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) gained 23.2% to $7.18 after Trump said he would double their tariffs to 50%.</li>
<li>Century Aluminum Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) rose 22% to $18.89 after Trump said he would double their tariffs to 50%.</li>
<li>Liquidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) gained 18.2% to $17.64 after the company announced it began shipping its newly FDA-approved Yutrepia. Additionally, Needham raised its price target on the stock from $25 to $32.</li>
<li>REGENXBIO Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) jumped 16.4% to $10.30.</li>
<li>Tempus AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) gained 14.1% to $62.95 after the company introduced its fuses program for precision-based medicine and xM for advanced cancer treatment response monitoring.</li>
<li>First Majestic Silver Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) rose 10.6% to $6.83.</li>
<li>Steel Dynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) surged 10.5% to $135.93. Shares of steel and aluminum stocks traded higher after Trump said he would double their tariffs to 50%.</li>
<li>Hecla Mining Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) gained 10.4% to $5.67.</li>
<li>Nucor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) gained 10% to $120.20. BMO Capital analyst Katja Jancic upgraded Nucor from Market Perform to Outperform and raised the price target from $140 to $145.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) rose 6.2% to $2.8250. ImmunityBio received FDA expanded access authorization for the treatment of Lymphopenia with ANKTIVA in patients with solid tumors</li>
<li>Eldorado Gold Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGO#NYSE">EGO</a>) rose 6.1% to $21.32.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/06/45719355/top-3-utilities-stocks-that-may-crash-in-june">Top 3 Utilities Stocks That May Crash In June</a> </li>
</ul>
Photo via Shutterstock

APLD

BPMC

CENX

IBRX

KYMR

LQDA

RGNX

STLD

VERA

Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday

WIIM

PAAS

RGLD

SBSW

Shares of precious metals stocks are trading higher amid strength in gold and silver.

TD Securities analyst Wayne Lam maintains Hecla Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) with a Hold and lowers the price target from $6 to $5.

Price Target

Analyst Ratings

TD Securities Maintains Hold on Hecla Mining, Lowers Price Target to $5

Shares of precious metals stocks are trading higher amid a rise in the price of gold and silver.

BMO Capital analyst Kevin O'Halloran downgrades Hecla Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) from Outperform to Market Perform and lowers the price target from $7.5 to $5.5.

Downgrades

BMO Capital Downgrades Hecla Mining to Market Perform, Lowers Price Target to $5.5

Hecla Mining shares are trading lower after the company reported worse-than-expected Q1 adjusted EPS results.

Hecla Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HL#NYSE">HL</a>) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 percent. This is a 300 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $261.34 million which beat the analyst consensus estimate of $236.26 million by 10.61 percent. This is a 37.89 percent increase over sales of $189.53 million the same period last year.

Comments

Hecla Mining

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL